It should be noted, however, that another recent study reported that BL cells do not have a hyperactivated PI3K-AKT pathway and are not sensitive to AKT knockdown or inhibition in contrast to GCB DLBCL cells [111]. This evidence concerns the gene AKT1 and Burkitt lymphoma.